Shanghai Xintan Venture Capital

Shanghai Xintan Medical Technology, also known as Xintan Medical or CoreProbe Medical, is a medical device company based in Shanghai, China, specializing in high-end intravascular imaging solutions. The company develops advanced Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) systems, including integrated dual-modality imaging catheters that provide simultaneous visualization of coronary anatomy. These technologies are designed to assist clinicians in the precise diagnosis and treatment of cardiovascular diseases, particularly during percutaneous coronary interventions (PCI). Xintan Medical has secured significant investment from major firms like Sequoia China and Legend Capital to advance its R&D and commercialization efforts.